Literature DB >> 17897674

Investigating the substrate specificity and oligomerisation of the leader protease of foot and mouth disease virus using NMR.

Regina Cencic1, Christina Mayer, Maria A Juliano, Luiz Juliano, Robert Konrat, Georg Kontaxis, Tim Skern.   

Abstract

The leader protease (Lbpro) of foot-and-mouth disease virus frees itself during translation from the viral polyprotein by cleavage between its own C terminus and the N terminus of the subsequent protein, VP4. Lbpro also specifically cleaves the host proteins eukaryotic initiation factor (eIF) 4GI and 4GII, thus disabling host cell protein synthesis. We used NMR to study full-length Lbpro as well as a shortened species lacking six C-terminal amino acid residues (sLbpro) to examine the mechanism of self-processing, the quaternary structure and the substrate specificity. Both Lbpro forms have the same structure in solution as in the crystal. In the solution structure of sLbpro, the 12 residue C-terminal extension was flexible and disordered. In contrast, the 18 residue C-terminal extension of full-length Lbpro was bound by the substrate-binding site of a neighbouring molecule, resulting in the formation of a stable dimer in solution. The Lbpro dimer could not be dissociated by increasing the ionic strength or by dilution. Furthermore, titration with model peptides mimicking the substrates destabilised the dimer interface without dissociating the dimer. The peptides were, however, bound by sLbpro in the canonical substrate binding site. Peptide binding gave rise to chemical shifts of residues around the sLbpro substrate binding site. Shifts of Asn146 and Glu147 indicated that these residues might form the enzyme's S1' site and interact with the P1' arginine residue of the eIF4GI cleavage site. Furthermore, differences in substrate specificity between sLbpro and Lbpro observed with an in vitro translated protein indicate some involvement of the C terminus in substrate recognition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17897674     DOI: 10.1016/j.jmb.2007.08.061

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Mapping inhibitor binding modes on an active cysteine protease via nuclear magnetic resonance spectroscopy.

Authors:  Gregory M Lee; Eaman Balouch; David H Goetz; Ana Lazic; James H McKerrow; Charles S Craik
Journal:  Biochemistry       Date:  2012-12-10       Impact factor: 3.162

Review 2.  The leader proteinase of foot-and-mouth disease virus: structure-function relationships in a proteolytic virulence factor.

Authors:  Jutta Steinberger; Tim Skern
Journal:  Biol Chem       Date:  2014-10       Impact factor: 3.915

Review 3.  Multifunctional roles of leader protein of foot-and-mouth disease viruses in suppressing host antiviral responses.

Authors:  Yingqi Liu; Zixiang Zhu; Miaotao Zhang; Haixue Zheng
Journal:  Vet Res       Date:  2015-10-28       Impact factor: 3.683

Review 4.  Structure and Function of Viral Deubiquitinating Enzymes.

Authors:  Ben A Bailey-Elkin; Robert C M Knaap; Marjolein Kikkert; Brian L Mark
Journal:  J Mol Biol       Date:  2017-06-16       Impact factor: 5.469

5.  Comparison of self-processing of foot-and-mouth disease virus leader proteinase and porcine reproductive and respiratory syndrome virus leader proteinase nsp1α.

Authors:  Jutta Steinberger; Georg Kontaxis; Chiara Rancan; Tim Skern
Journal:  Virology       Date:  2013-06-04       Impact factor: 3.616

6.  NMR analysis of the interaction of picornaviral proteinases Lb and 2A with their substrate eukaryotic initiation factor 4GII.

Authors:  Martina Aumayr; Sofiya Fedosyuk; Katharina Ruzicska; Carla Sousa-Blin; Georg Kontaxis; Tim Skern
Journal:  Protein Sci       Date:  2015-10-04       Impact factor: 6.725

7.  Foot-and-mouth disease virus leader proteinase: structural insights into the mechanism of intermolecular cleavage.

Authors:  Jutta Steinberger; Irina Grishkovskaya; Regina Cencic; Luiz Juliano; Maria A Juliano; Tim Skern
Journal:  Virology       Date:  2014-09-19       Impact factor: 3.616

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.